Pharmacokinetics of esomeprazole in patients with liver cirrhosis
Henrik Sjövall(Sahlgrenska University Hospital), Mohammed Hassan‐Alin(AstraZeneca (United Kingdom)), Kerstin Röhss(AstraZeneca (Sweden)), Irmelin Hagman, Johan Holmberg(University of California, Los Angeles)
Cited by 7
Related Papers
Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole
|Alimentary Pharmacology & Therapeutics|2001|175
Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects
|European Journal of Clinical Pharmacology|2000|140
Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole
|British Journal of Clinical Pharmacology|1998|124
Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype
|Nature Immunology|2016|104